Inozyme Pharma Inc (NASDAQ: INZY) Hogging The Spotlight Today
Currently, there are 61.77M common shares owned by the public and among those 41.65M shares have been available to trade. The company’s stock has a 5-day price change of -6.78% and -22.67% over the past three months. INZY shares are trading 3.29% year to date (YTD), with the 12-month market performance down to -20.72% lower. […]
